✦ LIBER ✦

Subcutaneous octreotide for the prevention of early variceal rebleeding

✍ Scribed by V DeLedinghen; M P Ripault; C Silvain; M Beauchant; N Raffoux; S Bouquet

Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 146 KB
Volume: 23
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.510230443

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Octreotide versus terlypressin in acute

Octreotide versus terlypressin in acute variceal hemorrhage in liver cirrhosis Emergency control and prevention of early rebleeding

✍ Pedretti, G. ;Elia, G. ;Calzetti, C. ;Magnani, G. ;Fiaccadori, F. 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 671 KB

Sucralfate for the prevention of early r

Sucralfate for the prevention of early rebleeding following injection sclerotherapy for esophageal varices

✍ Rex J. Polson; David Westaby; Alexander E. S. Gimson; Peter C. Hayes; Anthony J. 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB

One hundred eighty patients with variceal bleeding and treated by long-term sclerotherapy were randomized into a prospective randomized controlled clinical trial to assess the efficacy of sucralfate in reducing the frequency of rebleeding from esophageal ulceration prior to variceal obliteration. Ov

Sclerotherapy plus octreotide versus scl

Sclerotherapy plus octreotide versus sclerotherapy alone in the prevention of early rebleeding from esophageal varices: A randomized, double-blind, placebo-controlled, multicenter trial

✍ Massimo Pkimignani; Bruno Andreoni; Luca Carpinelli; Alfonso Capria; Gabriele Ro 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 659 KB

Because of its ability to decrease portal pressure, azygos blood flow, and postprandial splanchnic hyperemia, octreotide administration could be effective in reducing early rebleeding in patients undergoing endoscopic variceal sclerotherapy (EVS). We report the results of a trial comparing EVS + oct

Transjugular intrahepatic portosystemic

Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage

✍ Luis García-Villarreal; Francisco Martínez-Lagares; Angel Sierra; Clemencia Guev 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 1 views

Hemodynamic response–guided therapy for

Hemodynamic response–guided therapy for prevention of variceal rebleeding: An uncontrolled pilot study

✍ Antonio González; Salvador Augustin; Mercedes Pérez; Joan Dot; Esteban Saperas; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

The clinical usefulness of assessing hemodynamic response to drug therapy in the prophylaxis of variceal rebleeding is unknown. An open-labeled, uncontrolled pilot trial was performed to evaluate the feasibility and efficacy of using the hemodynamic response to pharmacological treatment to guide the

Transjugular intrahepatic portosystemic

Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis

✍ George V. Papatheodoridis; John Goulis; Gioacchino Leandro; David Patch; Andrew 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 2 views

Endoscopic treatment (ET) is frequently used to prevent variceal rebleeding but this still occurs in about 50% of patients. Recently, transjugular intrahepatic portosystemic shunt (TIPS) has been compared with ET in several trials. Using a meta-analysis, we evaluated randomized trials comparing TIPS